Reduced hepatic synthesis of calcidiol in uremia

Journal of the American Society of Nephrology

Volumn 21, Issue 9, 2010, Pages 1488-1497

  Michaud, Josée ^a,b   Naud, Judith ^a,b   Ouimet, Denis ^a   Demers, Christian ^b   Petit, Jean Luc ^b   Leblond, Francois A ^a   Bonnardeaux, Alain ^a   Gascon Barré, Marielle ^b   Pichette, Vincent ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALFACALCIDOL; CALCIFEDIOL; CALCITRIOL; CHOLESTANETRIOL 26 MONOOXYGENASE; COLECALCIFEROL; CYTOCHROME P450; CYTOCHROME P450 2C11; CYTOCHROME P450 2J3; CYTOCHROME P450 3A2; PARATHYROID HORMONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; KIDNEY FUNCTION; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PRIORITY JOURNAL; RAT; UREMIA; VITAMIN BLOOD LEVEL; ANIMAL; BIOSYNTHESIS; CELL CULTURE; HYDROXYLATION; LIVER; MALE; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; CALCIFEDIOL; CELLS, CULTURED; CHOLECALCIFEROL; CHOLESTANETRIOL 26-MONOOXYGENASE; HYDROXYLATION; LIVER; MALE; PARATHYROID HORMONE; PARATHYROIDECTOMY; RATS; RATS, SPRAGUE-DAWLEY; UREMIA;

EID: 77956529459     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009080815     Document Type: Article

References (59)

1. Elder GJ, Mackun K: 25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease. J Bone Miner Res 21: 1778-1784, 2006
2. LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q, Graves KL, Moe SM: Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the United States. Am J Kidney Dis 45: 1026-1033, 2005 (Pubitemid 40806515)
3. Bouchard J, Ouimet D, Vallee M, Leblanc M, Pichette V: Effect of vitamin D supplementation on calcidiol and parathyroid hormone levels. Perit Dial Int 28: 565, 2008
4. Bouchard J, Ouimet D, Vallee M, Lafrance JP, Leblanc M, Senecal L, Bonnardeaux A, Mathieu JP, Pichette V: Comparison of the prevalence of calcidiol insufficiency in predialysis and osteoporotic populations. Int Urol Nephrol 41: 983-988, 2009
5. National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42: S1-S201, 2003
6. Gonzalez EA, Sachdeva A, Oliver DA, Martin KJ: Vitamin D insufficiency and deficiency in chronic kidney disease: A single center observational study. Am J Nephrol 24: 503-510, 2004 (Pubitemid 39656665)
7. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL: Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the Study to Evaluate Early Kidney Disease. Kidney Int 71: 31-38, 2007 (Pubitemid 44967731)
8. Johal M, Levin A: Vitamin D and parathyroid hormone in general populations: Understandings in 2009 and applications to chronic kidney disease. Clin J Am Soc Nephrol 4: 1508-1514, 2009
9. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr, Tonelli M, Thadhani R: Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72: 1004-1013, 2007 (Pubitemid 47530570)
10. Jean G, Charra B, Chazot C: Vitamin D deficiency and associated factors in hemodialysis patients. J Ren Nutr 18: 395-399, 2008
11. Wang AY, Lam CW, Sanderson JE, Wang M, Chan IH, Lui SF, Sea MM, Woo J: Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: A 3-y prospective cohort study. Am J Clin Nutr 87: 1631-1638, 2008 (Pubitemid 351872624)
12. Holick MF: Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80: 1678S-1688S, 2004
13. Zittermann A, Koerfer R: Vitamin D in the prevention and treatment of coronary heart disease. Curr Opin Clin Nutr Metab Care 11: 752-757, 2008
14. Heaney RP: Vitamin D in health and disease. Clin J Am Soc Nephrol 3: 1535-1541, 2008
15. Palmer SC, McGregor DO, Macaskill P, Craig JC, Elder GJ, Strippoli GF: Meta-analysis: Vitamin D compounds in chronic kidney disease. Ann Intern Med 147: 840-853, 2007 (Pubitemid 351664426)
16. Zisman AL, Hristova M, Ho LT, Sprague SM: Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol 27: 36-43, 2007 (Pubitemid 46364539)
17. Al-Aly Z, Qazi RA, Gonzalez EA, Zeringue A, Martin KJ: Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis 50: 59-68, 2007 (Pubitemid 46962851)
18. Tokmak F, Quack I, Schieren G, Sellin L, Rattensperger D, Holland-Letz T, Weiner SM, Rump LC: High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol Dial Transplant 23: 4016-4020, 2008
19. Zierold C, Darwish HM, DeLuca HF: Identification of a vitamin D-response element in the rat calcidiol (25-hydroxyvitamin D3) 24-hydroxylase gene. Proc Natl Acad Sci U S A 91: 900-902, 1994 (Pubitemid 24984810)
20. DeLuca HF: The vitamin D story: A collaborative effort of basic science and clinical medicine. FASEB J 2: 224-236, 1988
21. Ohyama Y, Yamasaki T: Eight cytochrome P450s catalyze vitamin D metabolism. Front Biosci 9: 3007-3018, 2004
22. Brown AJ, Dusso A, Slatopolsky E: Vitamin D. Am J Physiol 277: F157-F175, 1999
23. Dusso AS, Brown AJ, Slatopolsky E: Vitamin D. Am J Physiol Renal Physiol 289: F8-F28, 2005
24. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW: Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A 101: 7711-7715, 2004
25. Prosser DE, Jones G: Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 29: 664-673, 2004
26. Yamasaki T, Izumi S, Ide H, Ohyama Y: Identification of a novel rat microsomal vitamin D3 25-hydroxylase. J Biol Chem 279: 22848-22856, 2004 (Pubitemid 38685585)
27. Van Peer AP, Belpaire FM: Hepatic oxidative drug metabolism in rats with experimental renal failure. Arch Int Pharmacodyn Ther 228: 180-183, 1977 (Pubitemid 8167459)
28. Leber HW, Schutterle G: Oxidative drug metabolism in liver microsomes from uremic rats. Kidney Int 2: 152-158, 1972
29. Leber HW, Gleumes L, Schutterle G: Enzyme induction in the uremic liver. Kidney Int Suppl S43-S48, 1978
30. Patterson SE, Cohn VH: Hepatic drug metabolism in rats with experimental chronic renal failure. Biochem Pharmacol 33: 711-716, 1984 (Pubitemid 14166437)
31. Uchida N, Kurata N, Shimada K, Nishimura Y, Yasuda K, Hashimoto M, Uchida E, Yasuhara H: Changes of hepatic microsomal oxidative drug metabolizing enzymes in chronic renal failure (CRF) rats by partial nephrectomy. Jpn J Pharmacol 68: 431-439, 1995
32. Leblond F, Guevin C, Demers C, Pellerin I, Gascon-Barre M, Pichette V: Downregulation of hepatic cytochrome P450 in chronic renal failure. J Am Soc Nephrol 12: 326-332, 2001 (Pubitemid 32116374)
33. Guevin C, Michaud J, Naud J, Leblond FA, Pichette V: Down-regulation of hepatic cytochrome P450 in chronic renal failure: role of uremic mediators. Br J Pharmacol 137: 1039-1046, 2002 (Pubitemid 35440744)
34. Michaud J, Dubé P, Naud J, Leblond FA, Desbiens K, Bonnardeaux A, Pichette V: Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450. Br J Pharmacol 144: 1067-1077, 2005 (Pubitemid 40593005)
35. Michaud J, Naud J, Chouinard J, Desy F, Leblond FA, Desbiens K, Bonnardeaux A, Pichette V: Role of parathyroid hormone in the down-regulation of liver cytochrome P450 in chronic renal failure. J Am Soc Nephrol 17: 3041-3048, 2006 (Pubitemid 44707764)
36. Simard E, Naud J, Michaud J, Leblond FA, Bonnardeaux A, Guillemette C, Sim E, Pichette V: Downregulation of hepatic acetylation of drugs in chronic renal failure. J Am Soc Nephrol 19: 1352-1359, 2008
37. Clements MR, Davies M, Fraser DR, Lumb GA, Mawer EB, Adams PH: Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism. Clin Sci (Lond) 73: 659-664, 1987 (Pubitemid 18013299)
38. Binkley N, Novotny R, Krueger D, Kawahara T, Daida YG, Lensmeyer G, Hollis BW, Drezner MK: Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab 92: 2130-2135, 2007 (Pubitemid 46997111)
39. Okuda S, Oh Y, Tsuruda H, Onoyama K, Fujimi S, Omae T, Fujishima M: Rapidly progressive renal deterioration in partially nephrectomized rats with experimental membranous nephropathy. Nephron 41: 359-364, 1985 (Pubitemid 16247662)
40. Esposito C, Villa L, Grosjean F, Mangione F, Esposito V, Castoldi F, Serpieri N, Arra M, Pertile E, Maggi N, Valentino R, Dal Canton A: Rapamycin reduces proteinuria and renal damage in the rat remnant kidney model. Transplant Proc 41: 1370-1371, 2009
41. Auwerx J, De Keyser L, Bouillon R, De Moor P: Decreased free 1,25-dihydroxycholecalciferol index in patients with the nephrotic syndrome. Nephron 42: 231-235, 1986 (Pubitemid 16156291)
42. Sato KA, Gray RW, Lemann J Jr: Urinary excretion of 25-hydroxyvitamin D in health and the nephrotic syndrome. J Lab Clin Med 99: 325-330, 1982 (Pubitemid 12138201)
43. Goldstein DA, Haldimann B, Sherman D, Norman AW, Massry SG: Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function. J Clin Endocrinol Metab 52: 116-121, 1981 (Pubitemid 11217851)
44. Houghton LA, Vieth R: The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 84: 694-697, 2006
45. DeVille J, Thorp ML, Tobin L, Gray E, Johnson ES, Smith DH: Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease. Nephrology (Carlton) 11: 555-559, 2006 (Pubitemid 44951240)
46. Al-Aly Z: Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients: The need for randomized trials. Kidney Int 72: 909-911, 2007
47. Niwa T, Murayama N, Yamazaki H: Oxidation of endobiotics mediated by xenobiotic-metabolizing forms of human cytochrome P450. Curr Drug Metab September 1, 2009 [epub ahead of print]
48. Miller WL, Portale AA: Vitamin D biosynthesis and vitamin D 1 alpha-hydroxylase deficiency. Endocr Dev 6: 156-174, 2003
49. Massry SG, Smogorzewski M: Parathyroid hormone, chronic renal failure and the liver. Kidney Int Suppl 62: S5-S7, 1997 (Pubitemid 27489392)
50. Wolf M: Fibroblast growth factor 23 and the future of phosphorus management. Curr Opin Nephrol Hypertens 18: 463-468, 2009
51. Quarles LD: Endocrine functions of bone in mineral metabolism regulation. J Clin Invest 118: 3820-3828, 2008
52. Klin M, Smogorzewski M, Ni Z, Zhang G, Massry SG: Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone. J Clin Invest 97: 2167-2173, 1996 (Pubitemid 26165706)
53. Hollis BW, Kilbo T: The assay of circulating 1,25(OH)2D using non-end-capped C18silica (Ci8-OH): Performance and validation. In: Vitamin D: Molecular, Cellular, and Clinical Endocrinology, edited by Anthony W, Norman KS, Grigoleit HG, van Herrath D, Berlin, Walter de Gruyter and Co., 1988, pp 710-719
54. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979
55. Lemay J, Demers C, Hendy GN, Delvin EE, Gascon-Barre M: Expression of the 1,25-dihydroxyvitamin D3-24-hydroxylase gene in rat intestine: Response to calcium, vitamin D3 and calcitriol administration in vivo. J Bone Miner Res 10: 1148-1157, 1995
56. Chow EC, Sun H, Khan AA, Groothuis GM, Pang KS: Effects of 1alpha, 25-dihydroxyvitamin D3 on transporters and enzymes of the rat intestine and kidney in vivo. Biopharm 31: 91-108, 2010
57. Rahmaniyan M, Patrick K, Bell NH: Characterization of recombinant CYP2C11: A vitamin D 25-hydroxylase and 24-hydroxylase. Am J Physiol Endocrinol Metab 288: E753-E760, 2005 (Pubitemid 40397211)
58. Su P, Rennert H, Shayiq RM, Yamamoto R, Zheng YM, Addya S, Strauss JF 3rd, Avadhani NG: A cDNA encoding a rat mitochondrial cytochrome P450 catalyzing both the 26-hydroxylation of cholesterol and 25-hydroxylation of vitamin D3: Gonadotropic regulation of the cognate mRNA in ovaries. DNA Cell Biol 9: 657-667, 1990 (Pubitemid 20385624)
59. Tso JY, Sun XH, Kao TH, Reece KS, Wu R: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13: 2485-2502, 1985